XF-73 MRSA drug molecule

XF-73 MRSA drug molecule

A624/0553 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 59.7MB

Downloadable file size: 554.1KB

Price image Pricing

Please login to use the price calculator


Caption: XF-73 MRSA drug, molecular model. This drug is in development to be used as a prophylactic against Staphylococcus aureus bacteria. It would be used for the nasal decolonisation of patients prior to them entering hospital. XF-73 has been shown to have rapid bactericidal activity against strains of S. aureus that are resistant to antibiotics, including MRSA (Methicillin-resistant S. aureus). Atoms are represented as spheres and are colour-coded: carbon (light blue), hydrogen (yellow), nitrogen (dark blue) and oxygen (red).

Release details: Model release not required. Property release not required.

Keywords: 1, anti-bacterial, anti-mrsa, anti-staphylococcal, antibacterial, antibacterial agent, antimicrobial, artwork, bactericidal, bactericide, biochemical, biochemistry, broad-spectrum, chemical, chemistry, compound, compounds, decolonise, dicationic porphyrin, drug, illustration, medical, medicine, methicillin-resistant staphylococcus, molecular model, molecule, molecules, mrsa, nasal decolonisation, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, porphyrin ring, prophylactic, prophylaxis, s aureus, single, structure, xf compound, xf series, xf-73

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.